Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 273 No 7320 p541
9 October 2004


Society summary


Review group seeks members’ views on Society and devolution

Members of the Royal Pharmaceutical Society are being urged to give their views on how the organisation should adapt and evolve to meet the political and social challenges brought about by devolution in Scotland and Wales.

A consultation document, published in The Pharmaceutical Journal this week (p543), asks for members’ general views on devolution, as well as their specific ideas on how the Society should strengthen itself to best meet the needs of pharmacists and their patients following devolution.

The consultation document has been drawn up by the Devolution Review Group, which was set up by the Society’s Council in February. The 12-strong group, chaired by Lord Fraser of Carmyllie, is examining the issues surrounding devolution in detail and will report back to Council in early 2005 with its recommendations.

The document begins by setting out the background to the review and, to help members respond, sets out 20 main functions of the Society, with examples of the types of activity that come under each function. It goes on to ask six specific questions about devolution.

The first question is a general one about how the Society should relate to its members and the pharmacy profession in the three home countries in its three roles of professional body, regulator and public voice of pharmacy. The second question relates to the formulation of Society policies for England, Scotland and Wales as well as for Britain and the acceptability of implementing a Society policy differently in England, Scotland and Wales.

Another question concerns the possibility of changing the role, remit and membership of the Society’s Scottish Executive and Welsh Executive to reflect devolution. The other three questions relate to the specific topics of education policy, European issues and disciplinary hearings.

Michele Savage, the Society’s project manager for the devolution review said: “As part of its reform programme, the Society now needs to consider a framework that will reflect devolution in Scotland and Wales including a review of function, structures and ways of working and will include the flexibility to extend to any future devolved administration in England. This is truly about shaping the Society’s future and the Devolution Review Group needs the views of as many Society members as possible to help formulate its recommendations for the way forward.”

Members have until 20 November to respond to the consultation.

As well as seeking individual pharmacists’ views through this document, the review group is consulting representatives of pharmacy bodies in Wales and Scotland. It is also planning to take further evidence from some of the key stakeholders groups at meetings in Edinburgh on 26 October and Cardiff on 8 and 9 November. These meetings are open to members of the Society. Anyone wishing to attend should contact Michele Savage (tel 020 7572 2547; e-mail michele.savage@rpsgb.org).

A further consultation document is to go out to a wider group of organisations and bodies outside pharmacy, so that the review group can learn about their views of devolution and how they have managed the changes it has brought about.

Back to Top


©The Pharmaceutical Journal